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Abstract
Influenza virus infection accounts for significant morbidity and mortality world-wide. Interactions of the virus with host cells,
particularly those of the macrophage lineage, are thought to contribute to various pathological changes associated with
poor patient outcome. Development of new strategies to treat disease therefore requires a detailed understanding of the
impact of virus infection upon cellular responses. Here we report that human blood-derived monocytes could be readily
infected with the H3N2 influenza virus A/Udorn/72 (Udorn), irrespective of their phenotype (CD14
++/CD16
2, CD14
++/CD16
+
or CD14
dimCD16
++), as determined by multi-colour flow cytometry for viral haemagglutinin (HA) expression and cell surface
markers 8–16 hours post infection. Monocytes are relatively resistant to influenza-induced cell death early in infection, as
approximately 20% of cells showed influenza-induced caspase-dependent apoptosis. Infection of monocytes with Udorn
also induced the release of IL-6, IL-8, TNFa and IP-10, suggesting that NS1 protein of Udorn does not (effectively) inhibit this
host defence response in human monocytes. Comparative analysis of human monocyte-derived macrophages (Mph)
demonstrated greater susceptibility to human influenza virus than monocytes, with the majority of both pro-inflammatory
Mph1 and anti-inflammatory/regulatory Mph2 cells expressing viral HA after infection with Udorn. Influenza infection of
macrophages also induced cytokine and chemokine production. However, both Mph1 and Mph2 phenotypes released
comparable amounts of TNFa, IL-12p40 and IP-10 after infection with H3N2, in marked contrast to differential responses to
LPS-stimulation. In addition, we found that influenza virus infection augmented the capacity of poorly phagocytic Mph1
cells to phagocytose apoptotic cells by a mechanism that was independent of either IL-10 or the Mer receptor tyrosine
kinase/Protein S pathway. In summary, our data reveal that influenza virus infection of human macrophages causes
functional alterations that may impact on the process of resolution of inflammation, with implications for viral clearance and
lung pathology.
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Introduction
Seasonal influenza infection annually affects about 10% of the
population. Although in most patients the infection is self-limiting
and resolves over time, the virus can also cause severe viral
pneumonia, secondary bacterial infections, respiratory failure and
death, particularly in older patients or in the very young. Each
year one million influenza-associated deaths are attributed to
seasonal influenza strains [1,2,3], while the emergence of
pandemic strains poses an even greater health threat. Current
antiviral strategies for treatment include inhibitors of the influenza
virus M2 ion channels (amantadine and rimantadine) or inhibition
of neuraminidase activity (neuraminidase inhibitors) to limit viral
spread [4]. However, there is a growing appreciation that innate
and adaptive immune regulatory mechanisms are pivotal deter-
minants of disease outcome [5]. In particular, macrophages and
their products (cytokines and chemokines) are thought to play a
key role in controlling infection and thus may represent targets for
new, effective therapeutic intervention strategies for treatment of
influenza virus infection. A detailed understanding of the interplay
between virus and macrophages and their potential impact upon
processes that are relevant to disease pathogenesis would be
required to utilize regulation of immune pathways to control
influenza disease.
Alveolar macrophages represent the predominant phagocyte
population present within the lung in the absence of infection.
They have an important homeostatic function, with a relatively
low capacity for phagocytosis and production of inflammatory
cytokines in the absence of activation. Following viral infection of
alveolar macrophages, their activation can dramatically alter
cytokine and growth factor production [6,7]. In addition, infection
of respiratory airway epithelial cells (AEC) with influenza virus
triggers release of cytokines and chemokines (including IP-10,
IFNb, RANTES and IL-6) [8] that promote the recruitment of
blood-derived inflammatory cells, including neutrophils and
monocytes [9,10,11]. Alveolar macrophage activation together
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29443with initiation of inflammatory cell recruitment contributes to
virus-induced pathology and mortality [12]. Recently, it has been
reported that H5N1 highly pathogenic avian influenza virus
induced production of very high levels of TNFa and IFNb in
monocyte-derived macrophages [13], raising the possibility that
high levels of cytokines produced by macrophages were associated
with excessive disease pathology. Consistent with this, mice lacking
TNFa and IL-1 receptors have reduced inflammatory responses
following infection [10], while macrophages lacking critical
counter-regulatory signalling pathways exhibited more severe lung
pathology [14]. Surprisingly, IL-10, which might be predicted to
have anti-inflammatory activity, was found to reduce development
of protective immunity in mice [15], indicating an additional level
of complexity in the cytokine regulation of immunity to virus
infection.
Influenza infection has been shown to trigger apoptosis in
MDCK and HeLa cells [16,17] and in lung airway epithelial cells
[18,19] and has been suggested to be important for virus clearance
in vivo [20], e.g. by directly inhibiting the production of new virus
[21] and triggering the release of pro-inflammatory cytokines by
bystander cells, thereby limiting both spread of infection and the
potential for promotion of inflammation. In addition, apoptotic
cell clearance has the potential to actively counter the production
of pro-inflammatory cytokine production and to initiate release of
immune-regulatory mediators (e.g. IL-10 and TGFb) that can
direct the resolution of inflammation [22]. Moreover, specific
removal of apoptotic cells by tissue phagocytes limits the potential
of infected cells to undergo secondary necrosis and release pro-
inflammatory stimuli (e.g. HMGB1, HSPs and formylated
peptides), proteases and oxidant species that could cause tissue
damage. However, evidence from animal models of influenza
infection suggests that reduction of AEC apoptosis can ameliorate
pathology and increases host survival [18], raising the possibility
that the net outcome of the responses may be dictated by host-,
cell- and/or pathogen specific factors [23].
While the impact of infection with influenza virus has been
reasonably well studied in murine models both in vitro and in vivo
[24], the susceptibility and functional responses of human innate
immune cells to influenza virus infection remains relatively ill-
defined. Specifically, the phenotype of human blood-derived
monocytes and macrophages infected with influenza virus has not
been reported and the extent of infectivity has not been assessed.
Here we address this by assessing human monocyte and
monocyte-derived macrophage function in the context of influenza
virus infection. In addition, we provide the first analysis of the
permissiveness of different subpopulations of human blood-derived
monocytes and well-defined monocyte-derived macrophage phe-
notypes to human influenza virus (Udorn; H3N2). Monocytes and
macrophages became infected with Udorn virus regardless of cell
phenotype and were found to be relatively resistant to caspase-
dependent influenza-induced cell death. In addition to inducing
cytokine and chemokine release by monocytes and macrophages,
influenza virus infection caused increased macrophage capacity for
phagocytosis of apoptotic cells. Together, these findings increase
our understanding of the interplay between human influenza virus
and host cell responsiveness, which may ultimately lead to new
strategies to modulate disease outcome.
Results
Influenza infection of human blood monocytes
The capacity of human monocytes to become infected with an
H3N2 seasonal human influenza virus (Udorn) was determined by
assessment of viral haemagglutinin (HA) expression using both
flow cytometry and confocal microscopy. These experiments were
performed with mononuclear cells (MNC) in suspension culture
using Teflon pots to prevent adherence of monocytes to tissue
culture plastic, which has been shown to result in activation,
including induction of early response genes (c-fos) and cytokines
[25]. Incubation of MNC in the presence of Udorn (but not UV-
inactivated virus) caused a change in forward and side scatter of
cells as assessed by flow cytometry (Figure 1A), suggesting that
Udorn infection caused changes in cell size/granularity. However,
there was no direct correlation between altered laser scatter
profiles and viral infection, since HA was also expressed by non-
shifted cells. Monocytes were found to express HA both
intracellularly by confocal microscopy 8 h post infection (p.i.)
(Figure 1B) as well as at the cell surface, as determined with flow
cytometry (Figure 1C). In contrast, lymphocytes present within
MNC populations incubated with Udorn, or purified CD3
+ve cells
(isolated using immunomagnetic selection) did not express HA as
assessed by flow cytometry (data not shown). Infection of
monocytes with Udorn was not dependent on the presence of
lymphocytes, as monocytes isolated using CD14
+ immunomag-
netic selection incubated with Udorn (MOI=2) showed a similar
HA expression at 8 h p.i. to gated monocytes in MNC samples
(48.765.5 (n=3) and 47.166.5 (n=9), respectively; data not
shown). The extent of HA expression was related to virus dose
(Figure 1C and Figure 1D; MOI=1 vs MOI=5: p,0.05) and
showed a strict time dependency (data not shown). The infection
was productive, with virion release in a virus-dose and time-
dependent manner (41.769.5 (MOI=0.5) and 110.2622.8
(MOI=2) in PFU/ml 610
3 for 3 donors (8 h p.i.), and data not
shown). Finally, we tested whether adherence of monocytes to
tissue culture plastic would impact upon HA expression.
Surprisingly, we did not find a significant difference in infectivity
when monocytes were cultured in suspension or adherent to tissue
culture plates (Figure 1E), indicating that adhesion-induced
activation does not confer protection against infection.
Infection of different human monocyte subsets with
influenza virus
We next assessed whether monocyte subsets present in the
circulation differ in their capacity for influenza virus infection.
Expression of viral HA on monocyte subsets was assessed using a
combination of CD14, CD16 and CCR2 (CD192) monoclonal
antibodies. Populations of monocytes with CD14
++/CD16
2
(classical), CD14
++/CD16
+ (intermediate) and CD14
dimCD16
++
(non-classical) expression profiles were readily detected in
uninfected (Figure 2A) and Udorn-infected MNC preparations
(Figure 2B–D), with CD14 positive, intermediate or dim, CD16
positive or negative and CCR2 positive or negative cells present.
There were no changes in the percentages of CD16 positive and
CD16 negative, or CCR2 positive and CCR2 negative monocyte
subpopulations observed following infection with Udorn (Table 1).
Although we did observe a decreased percentage of CD14 positive
cells and consequently an increased percentage of CD14 dim cells
8 h after infection, this was not statistically significant. These
experiments demonstrated that viral infectivity was not limited to
any specific monocyte subset. To dissect this further we performed
a flow cytometry-based assessment of sialic acid containing
glycoconjugates on monocytes and found similar staining by
Sambucus nigra agglutinin lectin (SNA I, which recognizes a(2,6)-
linked sialic acids) to classical (CD14
++/CD16
2) and non-classical
(CD14
dim/CD16
++) monocytes (fluorescence ratio non-classical:
classical monocytes=1.0660.1 (n=5); data not shown), while cell
staining with Maackia amurensis lectin II (Mal II, which binds to
a(2,3)-linked sialic acids) was ,2-fold stronger on non-classical
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non-classical:classical monocytes=1.8860.3 (n=5); data not
shown).
Influenza infection of human monocyte-derived
macrophages
To further explore the effects of monocyte differentiation status
upon susceptibility to infection with influenza we next treated
CD14
+ve monocytes with GM-CSF or M-CSF to drive differen-
tiation towards Mph1 (macrophages with pro-inflammatory
characteristics) or Mph2 (macrophages with anti-inflammatory
characteristics), respectively, as we reported previously [26]. These
experiments revealed that Udorn was capable of infecting human
blood monocyte-derived macrophages (Mph) irrespective of their
functional properties. Flow cytometric analyisis of Mph1 and
Mph2 (Figure 3A) indicated that both Mph phenotypes expressed
HA (Figure 3B) in a dose- (Figure 3C) and time- (Figure 3D)
dependent manner, following incubation with live, but not UV-
inactivated Udorn virus (Figure 3C). In a comparative analysis of
Figure 1. Influenza infection of human monocytes. Representative examples of laser scatter histograms of uninfected and Udorn-infected MNC
cultured in Teflon pots (A) and of HA expression in human monocytes as assessed by confocal microscopy (B) and flow cytometry (C). (D)H A
expression shows dose-dependency. (E) Plate adherence is not required for HA expression by infected monocytes as results are similar for cells
infected in Teflon pots and tissue culture plate. Bars represent means of 3–6 donors 6 SD. Unless otherwise indicated, data represent 8 h p.i. and
MOI=2. *: p,0.05.
doi:10.1371/journal.pone.0029443.g001
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infectivity (,1.8 fold) when compared with MNC incubated with
the same viral dose (Figure 3E; p,0.0001 for Mph1 and Mph2).
Of note, two epithelial cell lineages, A549 and MDCK cells, also
showed increased proportions of HA expression when compared
to monocytes (,1.7 fold and ,2.3 fold, respectively, with
MOI=2 at 8 h p.i.; data not shown). Moreover, with a high
virus dose we obtained near 100% infectivity for Mph1 (97%),
Mph2 (96%), A549 (91%) and MDCK (94%) cells, but not
monocytes (61%) (MOI=10, 8 h p.i.; data not shown). Western
blot analysis confirmed influenza virus replication in human
monocyte-derived Mph, as we detected viral NS1, NP, HA and
M1 proteins in cell lysates 8 h post infection with MOI=2 and
MOI=5 (Figure S1). These influenza proteins were not expressed
in mock-infected, UV-treated virus infected, or Udorn-infected
Mph treated with the protein synthesis inhibitor cycloheximide,
while b-actin was readily detected in all samples (Figure S1). Use of
high MOI induced high levels of apoptosis in monocytes and Mph
(see below), thus subsequent infection experiments were performed
with viral doses ranging from MOI=0.1 to 5. Interestingly, in a
series of paired experiments comparing Mph1 and Mph2 derived
from the same donors, the percentage of HA-positive cells was
significantly higher in Mph2 than Mph1 samples when using a
dose of MOI=2 for 8 h (Fig. 3E: 80.0962 vs 90.0162; p,0.01;
n=5 donors). Yet, virion release (which showed a virus-dose and
time dependency) was greater for Mph1 than Mph2 (representa-
tive example in triplicate: 157.5617.5 and 306.3638.1 (Mph1)
versus 7565 and 176.3611.3 (Mph2) in PFU/ml 610
3 for
MOI=2, 8 h and 24 h p.i., respectively (data not shown)).
Human monocytes and monocyte-derived macrophages
are resistant to influenza-induced apoptosis
To assess the relationship between infection with influenza virus
and the induction of apoptosis of human monocytes and Mph we
determined the percentage of apoptotic cells (AxV
+/PI
2) and
necrotic cells (AxV
+/PI
+) by flow cytometry (Figure 4A). We
observed reproducible induction of low percentages of apoptosis,
in the absence of detectable necrosis, following Udorn-infection of
monocytes and Mph for 8 h (Figure 4A and data not shown).
Induction of apoptosis was dependent on the extent of infection in
both monocytes and Mph, displaying a close relation to virus MOI
(Figure 4B and 4D, respectively) and infection time (data not
shown). Infection with a high virus load did induce relatively high
levels of AxV
+ve cells (Figure 4C and 4E, and data not shown).
Multi-colour flow cytometry revealed that apoptotic cells were
present in both the HA
+ve and HA
2ve population in monocyte-
Figure 2. Influenza infection of human monocyte subsets. (A) Double colour flow cytometry with anti-CD14 and CD16 antibodies allows
detection of various monocyte populations within human MNC populations (monocytes gated as shown in Figure 1). The CD14 (B), CD16 (C) and
CCR2 (D) positive and negative subpopulations are all susceptible to infection with Udorn, as HA
+ve cells could be detected in each of the
subpopulations (MOI=2, 8 h p.i.). Histogram and graphs are representative examples of 3 independent experiments.
doi:10.1371/journal.pone.0029443.g002
Table 1. Influenza infection of human monocyte subsets.
mock MOI 0.5 MOI 2
CD14 pos 66.969.5 56.9611.6 41.8615.3
CD14 inter 14.865.1 11.962.2 14.262.7
CD14 neg 16.265.8 28.9612.4 41.3616.6
CD16 pos 9.461.8 12.461.7 11.562.2
CD16 neg 90.461.7 87.661.6 88.562.2
CCR2 pos 5.461.6 8.561.3 6.361.7
CCR2 neg 94.661.6 91.561.3 93.761.8
The relative percentages of the various monocyte subsets in human MNC were
not affected by infection with Udorn virus (8 h p.i.) compared to mock-
infection. Data represent 3 independent experiments (mean 6SEM).
doi:10.1371/journal.pone.0029443.t001
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29443Figure 3. Influenza infection of human monocyte-derived macrophages. (A) Laser scatter histograms of mock- and Udorn-infected Mph1
and Mph2 cells. (B) HA expression by infected live Mph1 (dashed green line) and Mph2 (dashed blue line) cells over mock treated Mph1 (solid orange
line) and Mph2 (solid red line) as assessed by flow cytometry. HA expression shows dose (C) and time (D) dependency in both macrophage subsets.
(E) Mph1 and Mph2 show a higher HA
+ve cell percentage than monocytes. Flow plots are representative examples of 6 independent experiments.
Bars represent means of 4–9 experiments 6 SD. Unless otherwise indicated, data represent 8 h p.i. and MOI=2. **: p,0.01; ****: p,0.0001.
doi:10.1371/journal.pone.0029443.g003
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contribution of HA
+ve cells to the AxV
+ve pool increasing with
increasing virus dose (Figure 4C and 4E).
Caspase-dependent induction of HA expression in
influenza virus infected human monocytes
Given the association between virus infection and induction of
apoptosis shown in Figure 4, we next sought to determine the
impact of inhibiting caspase enzyme activity upon expression of
virus HA protein and induction of apoptosis in monocytes. As
would be expected, the proportion of monocytes that were
induced into apoptosis following incubation with Udorn was
greatly reduced by the pan-caspase inbibitor zVAD, with
proportions of annexin V
+ve cells comparable to those of mock-
infected cells (,8% for Udorn-infected cells and ,4% for mock-
infected cells (Figure 5A; reduction with MOI=2: p,0.05). The
inhibition of apoptosis was not overcome by increasing virus dose
Figure 4. Influenza infection induces apoptosis in human monocytes and monocyte-derived macrophages. (A) Influenza infection of
MNC increases the percentage of apoptotic (AxV
+/PI
2) but not necrotic (AxV
+/PI
+) monocytes, as assessed by flow cytometry (MOI=2). Infectious
Udorn virus, but not UV-inactivated virus (UV) induces apoptosis in human MNC (B) and human macrophages (both Mph1 & Mph2) (D) in a dose
dependent manner (B and D), with increasing numbers of apoptotic cells expressing HA with increasing virus dose in both cell types (MNC in C, and
Mph1 in E). Bars represent means of 8 (B)o r3( D) experiments 6SD, or representative examples (A,C,E). All experiments are 8 h p.i. *: p,0.05;
**: p,0.01.
doi:10.1371/journal.pone.0029443.g004
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was effective. Of note, zVAD did not interfere with virus
attachment to the cell or block virus replication, as Western blot
analysis demonstrated that zVAD treatment did not preclude
expression of influenza proteins NS1, HA, NP and M1 in Mph 8 h
pi with MOI=5 (Figure S1). In contrast to the almost complete
inhibition of Udorn-induced apoptosis in infected monocytes
treated with zVAD, expression of HA was still readily detectable
on zVAD-treated monocytes 8 h p.i. The proportion of HA
+ve
cells was reduced by ,50% in the presence of zVAD after
infection with MOI=2 (Figure 5B; p,0.001) and comparison of
the level of surface expression (mean fluorescent intensity (MFI) of
staining) of HA on gated monocytes revealed a two-fold MFI
reduction after zVAD treatment: 64.868.2% reduction of MFI
with MOI=0.5 (n=3) and 70.465.4% reduction with MOI=2
(n=3) (data not shown). It is worth noting that previous reports
have shown that while early events in the viral life cycle such as
virus entry, genome release, and transcription and translation do
not rely on caspase activity, caspases are required for generation of
progeny virus [27], likely by enabling export of ribonucleoprotein
complexes from the nucleus to the cytoplasm of infected cells [28].
Cytokine release by influenza infected human monocyte-
and monocyte-derived macrophage subsets
We have previously shown that human monocyte-derived Mph
subsets show differential responses to TLR-4 ligand LPS, with
Mph1 secreting IL-12 but no IL-10, and Mph2 producing IL-10
but low levels of IL-12, following LPS stimulation [26,29]. We
therefore determined the impact of influenza virus infection upon
cytokine/chemokine production profiles in both Mph1 and Mph2
by ELISA. We found that Udorn-infection induced comparable
TNFa (Figure 6A), IL-12p40 (Figure 6B), IP-10 (Figure 6C) and
IL-6 (data not shown) levels in both Mph1 and Mph2. Influenza-
induced TNFa and IL-6 (Mph1 & Mph2) and IL-12 (Mph1) levels
were 5–20 fold lower than those induced by LPS, although
induction of IP-10 by influenza was similar to LPS-induced IP-10
(Mph1 and Mph2, respectively). Induction of TNFa, IL-12 and
IL-6 required the presence of live virus, as UV-inactivated Udorn
did not trigger secretion of these cytokines. In contrast, release of
IP-10 did not show this requirement, as IP-10 was also secreted
after incubation with UV-inactivated virus, especially in Mph2
(Figure 6C). Secretion of TNFa, IL-12p40, IP-10 and IL-6 showed
a dependency upon infection time (Figure 6 and data not shown)
and upon virus dose (data not shown). IL-8 production by Mph
was constitutive in mock-infected Mph1 and Mph2 cells, with no
or only a slight increase due to incubation with live- or UV-
inactivated virus for most donors (data not shown). We did not
detect IL-10 release in response to Udorn-infection in either Mph1
or Mph2 of any donor (n=6; data not shown). In contrast, Mph2
of these donors produced 2–7 ng/ml IL-10 following LPS
stimulation ([26] and data not shown). IL-33 was not produced
by either Mph subset 8–16 h after mock-infection, Udorn-
infection or LPS stimulation (data not shown). Similar to the
findings for Mph, infection of human monocytes with infectious
Udorn specifically induced secretion of TNFa, IL-6, IL-8 and IP-
10, levels of which were reduced to background levels when cells
were treated with the caspase inhibitor zVAD (Figure 5C and data
not shown). However, influenza infection of monocytes did not
induce production of IL-10, IL-12 or IL-33 (data not shown).
Influenza infection of human monocyte-derived
macrophages increases their capacity to phagocytose
apoptotic cells
The impact of virus infection on the function of Mph was next
investigated by examining the capacity for phagocytosis of two
distinct targets: latex microspheres (1 mm) and apoptotic neutro-
phils (,7 mm). Influenza infection did not affect uptake of
microspheres by either Mph population, even at high virus MOI
and high bead to macrophage ratios (percent phagocytosis at bead
to macrophage ratio of 10:1; mock-infected vs H3N2-infected was
63.561.2 vs 64.763.7 for Mph1, and 7562.3 vs 78.662.5 for
Figure 5. Caspase dependency of influenza-induced apoptosis,
HA expression and IP-10 production in human monocytes.
Apoptosis (A), HA expression (B) and IP-10 secretion (C) following
infection of human monocytes with influenza virus (8 h p.i.) are
dependent on caspase activity, as the pan-caspase inhibitor zVAD
reduces apoptosis, HA positivity and IP-10 release. Bars represent mean
6 SD of 3 independent experiments. *: p,0.05; ***: p,0.001.
doi:10.1371/journal.pone.0029443.g005
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in triplicate; data not shown). In contrast, there was a significant
increase in the proportion of Mph1 able to phagocytose apoptotic
neutrophils (Figure 7A) after infection with infectious Udorn virus
(p,0.001) but not UV-inactivated virus (Figure 7B), with an
average fold-increase of 4.161.3 (n=7). The increase in the
capacity for phagocytosis of neutrophils by infected Mph1 showed
a virus-dose dependency (Figure 7C). Similar results were obtained
when using apoptotic airway epithelial cell lines (A549 and Beas
2B cells) as targets (data not shown). In contrast, for Mph2 cells
there was no influenza-induced increase in phagocytosis of
apoptotic neutrophils (average fold increase for Mph2 was
0.9260.2 (n=5)) or epithelial cells (data not shown). Multi-laser
flow cytometry revealed that the fluorescent neutrophils were
ingested by HA
+ve as well as HA
2ve Udorn-infected Mph1 cells
(Figure 7D) and Mph2 cells (data not shown), with the percentage
of ingested neutrophils in HA
+ve Mph1 cells (but not HA
2ve Mph1
cells) increasing with increasing virus dose (Figure 7D).
The influenza infection-associated increase of phagocytosis could
not be mimicked with culture supernatant of Udorn-infected Mph,
as addition of (UV-inactivated) supernatants collected 12 h and 14 h
p.i. of Mph1 or Mph2 (MOI=1) onto non-infected Mph 2 h or 4 h
before phagocytosis did not affect subsequent uptake of apoptotic
neutrophils (Figure 7E and data not shown). The uptake of apoptotic
neutrophilsbyMph wasnot affectedbyaddition of rIL-10 orProtein
S 30 min prior to and during phagocytosis (data not shown).
Moreover, the influenza-induced increase of phagocytosis of
apoptotic neutrophils was not dependent on the Mer receptor
tyrosine kinase (Mertk) pathway, as addition of an anti-Mer blocking
antibody did not inhibit phagocytosis of apoptotic neutrophils, either
inmock-infectedor inUdorn-infectedMph (percent phagocytosisby
Udorn-infected macrophages +/2 aMer: 21.261.2 vs 20.863f o r
Mph1, and 56.762.5 vs 54.161 for Mph2 (representative
experiment performed in triplicate; data not shown)).
Discussion
We have established an influenza infection model using human
blood monocytes and monocyte-derived macrophages (Mph) to
gain a better understanding of the impact of virus infection upon
cellular responses in man. Monocytes could be infected with
influenza H3N2 strain A/Udorn/72 (Udorn), with ,50% of cells
expressing viral HA 8–16 h after infection (MOI=2). In contrast,
lymphocytes within MNC samples or as purified CD3
+ve cells did
not express HA, indicating a leukocyte cell type specific infectivity
profile for Udorn virus.
It is well established that circulating human monocytes can be
divided into distinct subpopulations based on specific cell surface
receptor profiles, including CD14 and CD16 [30,31,32,33]. These
‘classical’ (CD14
++/CD16
2), ‘intermediate’ (CD14
++/CD16
+) and
‘non-classical’ (CD14
dim/CD16
++) monocytes [34,35,36] display
distinct functional properties in vitro and in vivo [37,38], with
classical monocytes suggested to be pro-inflammatory, while the
non-classical cells patrol tissues and reportedly selectively recog-
nize nucleic acid [34]. Multi-colour flow cytometry revealed that
monocyte subsets expressed comparable levels of viral HA 8 h p.i.,
suggesting that influenza permissiveness is not restricted to specific
monocyte populations, nor dependent on CD14, as has been
reported for influenza-induced cytokine/chemokine release [39].
Furthermore, although we observed a reduced percentage of
CD14
+ve cells (Table 1), this difference was not statistically
significant and likely due to loss of CD14 expression following
influenza-induced apoptosis rather than a specific influenza-
mediated down-regulation of CD14, as previously suggested [39].
Figure 6. Influenza infection of human monocyte-derived
macrophages induces cytokine/chemokine release. Influenza
infection induces secretion of TNFa (A), IL-12p40 (B) and IP-10 (C)b y
human Mph1 and Mph2 cells, as assessed by ELISA of culture
supernatants of mock-infected, UV-inactivated (8 h p.i.) and infectious
Udorn virus-infected cells (MOI=2, 8 and 24 h p.i.). Data are mean
protein levels 6 SD; n=4–8 experiments.
doi:10.1371/journal.pone.0029443.g006
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restricted permissiveness, as classical (CD14
++/CD16
2) and non-
classical (CD14
dim/CD16
++) monocytes showed similar staining by
SNA I. This lectin preferentially recognizes a(2,6)-linked sialic
acids [40], while Udorn virus exhibits preferential sialic acid
cleavage activity for a(2,6)-linked sialosides [41]. In contrast, cell
staining with MalII (which binds to a(2,3)-linked sialic acids) was
,2-fold stronger on non-classical monocytes compared to classical
monocytes, which potentially predisposes the former to infection
with human-, and especially avian influenza viruses. However, a
high-throughput neuraminidase substrate screen of a large pool of
influenza viruses of varied origin showed that sialic acid substrate
preference and the degree of sialic acid hydrolysis activity vary
significantly with virus strain- and NA type [41], suggesting that
extrapolating our findings to other influenza viruses should be
undertaken with caution. We conclude that even though their
Figure 7. Influenza infection of human monocyte-derived macrophages increases their capacity to phagocytose apoptotic cells. (A
and B) Infection of human Mph1 cells with Udorn virus increases phagocytosis of apoptotic neutrophils as determined with flow cytometry using
green fluorescent neutrophils. This increase, which is virus-dose dependent (C), was not seen when using UV-inactivated virus (B and C) or UV-
inactivated supernatants that were harvested 12 h p.i. of Mph1 and added 4 h prior to phagocytosis (E). (D) Green neutrophils (neuts) were ingested
by both HA negative and HA positive Mph1 cells. (B) Depicts 7 experiments 6 SD, while the other panels depict representative examples performed
in triplicate (mean 6 SD). Unless otherwise indicated, cells were infected for 16 h with MOI=1. **: p,0.01; ***: p,0.001.
doi:10.1371/journal.pone.0029443.g007
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(‘classical’) or anti-inflammatory (‘non-classical’) phenotype show a
comparable susceptibility to influenza A/Udorn/72 virus.
No difference in influenza virus infectivity of adherent versus
suspension-cultured monocytes was found, suggesting that adhe-
sion-induced monocyte activation [25] does not protect against
infection. Indeed, differentiation towards Mph increased suscep-
tibility to influenza nearly 2-fold, with ,80–90% of monocyte-
derived Mph expressing HA 8–16 h p.i. with Udorn virus.
Previously reported rapid expression of HA, NP and M1 protein
and cytokine release in GM-CSF-treated, A/Puerto Rico/8/34
virus-infected monocytes suggests that cell differentiation readily
confers susceptibility to influenza [42]. Altered surface glycosyla-
tion associated with Mph differentiation may facilitate virus
association. Induction of expression and activity of endogenous
neuraminidase 1 associated with monocyte differentiation (.3-fold
increase compared with other lysosomal proteins) may also
contribute to increased susceptibility [43]. Alternatively, reduced
susceptibility to virus-induced apoptosis in Mph versus monocytes
(Figure 4) may give rise to an apparent increased infectivity.
Human Mph, like monocytes, exhibit functional plasticity
[44,45,46,47]. We have previously described conditions for
differentiating monocytes into Mph with pro-inflammatory
(Mph1) or anti-inflammatory/regulatory (Mph2) characteristics
[26], with Mph2 expressing higher levels of scavenger receptor
CD163 and being more proficient phagocytes than Mph1 [26].
Here we report that both Mph types could be readily infected with
influenza virus. Mph2 showed a small, but significantly higher
permissiveness to Udorn infection than Mph1 in terms of HA
expression (,10%). Yet, Mph1 released more infectious virus than
Mph2 (,1.5-fold for MOI=2, 8 h p.i), as determined by plaque
assays. Further studies with infection dose- and temporal kinetics
are required to determine the significance of these observations in
terms of inflammatory responses following infection in vivo. The
polarized Mph1 and Mph2 studied here represent extreme ends of
a continuum of phenotypes and their in vivo counterparts are
currently not known [46,48]. They likely represent late-phase
monocyte/Mph and resident cells present during different phases
of the immune response following influenza virus infection,
respectively. Our data suggest that Mph are susceptible to
influenza virus infection throughout the course of disease. Mph
differentiation state in lungs of pathogen-exposed individuals may
critically determine disease outcome [29], and people with asthma,
a type-2 environment, show enhanced incidence of respiratory
infections [49]. Increased prevalence of Mph2-like cells may also
render individuals more susceptible to influenza infection.
In both monocytes and Mph, influenza virus infection resulted
in virus-dose dependent release of inflammatory cytokines/
chemokines. Somewhat surprisingly, Mph1 and Mph2 produced
similar cytokine responses following Udorn-infection. This finding
is in marked contrast with clearly distinct cytokine profiles of
Mph1 and Mph2 exposed to bacterial products [26,29,50],
sonicated mycobacteria [29,50], or infection with live bacteria
[29]. Influenza may induce similar signaling events in Mph1 and
Mph2, but whether this is influenza-specific or a general feature of
the response pathway to viruses as opposed to bacteria remains to
be determined. It is possible that pattern recognition receptors
sensing bacteria are differentially expressed by Mph1 and Mph2,
while receptors recognizing influenza virus are expressed similarly.
Cytokine production by human monocytes/Mph in cell culture
[39,42,51,52] and in situ in a lung tissue culture model [53] in
response to influenza virus has been reported previously. Of note,
with MOIs of 0.5–2 the Poisson distribution predicts that a certain
cell percentage will remain uninfected. To date no one has
dissected the contribution of the infected versus uninfected cells to
cytokine secretion following influenza A virus infection of
monocytes/Mph, and we can also not say with certainty that
cytokine production results directly from infection, nor whether it
is exclusively triggered in infected cells. However, the vast majority
of Mph secreting cytokines (Figure 6) express HA (Figure 3).
Moreover, we would expect to see different kinetics if there was a
significant contribution of uninfected cells to cytokine secretion
following Udorn infection (namely, reduced protein levels when
the uninfected cell percentage decreases and infected cell
percentage increases, while we see the opposite: increased protein
release with increased virus dose (Fig. 5) and infection time
(Figure 6)). Assuming there is a considerable contribution from
infected cells to the cytokine secretion, then future studies might
reveal whether and how cells of the Mph lineage override NS1-
mediated impairment of anti-influenza immune responses, includ-
ing blocking the correct processing and export of cellular mRNAs
from the nucleus to the cytoplasm [54,55,56]. There is a growing
body of evidence that certain NS1-mediated countermeasures are
influenza-strain specific [57,58,59]. Possibly, host cell-specific
differences in transcriptional regulation of anti-viral proteins are
also a determining factor as to whether or not viral NS1 can
counteract the cell’s protective responses.
We did not detect IL-33 in supernatants of Udorn-infected
human MNC (4 donors) and Mph1/Mph2 cells (6 donors) 8–16 h
p.i.. This finding contrasts with increased IL-33 mRNA and
protein by CD45
+ve cells [60], possibly alveolar Mph [61], in lungs
of influenza-infected mice. Influenza strain and/or inter-species
differences may account for this apparent discrepancy. In our
model, infection beyond 24 h caused excessive apoptosis and
experiments were typically performed for 8–16 h. Interestingly, Le
Goffic et al specifically report a positive association between the IL-
33 levels produced by murine and human lung epithelial cell lines
and the cytopathic effect of the influenza virus strain, raising the
possibility that IL-33 release is associated with virus-induced
apoptosis [60].
We found that cells of the Mph lineage exhibited relative
resistance to influenza-induced cell death early after infection with
MOIs 0.5–2, with apoptosis levels (as assessed by annexin V
staining) approximately 10–30%, while the majority of cells
expressed HA at the cell surface. Similarly, in Udorn-infected
MDCK and epithelial A549 cells, HA-expression precedes onset of
apoptosis at 8 h p.i. (MOI=2,) with 72% and 61% of cells
expressing HA, respectively, whilst apoptosis was 25% and 12% in
these populations (data not shown), corroborating our previous
findings [62]. Whether this ‘delay’ in Mph apoptosis compared to
HA expression is due to active strategies by the host cell to delay
apoptosis and allow engagement of various anti-viral mechanisms,
or whether the virus acts to delay host cell apoptosis to maximise
viral protein synthesis (Figure S1) and production of infectious
virions, remains to be determined. Apoptotic cell removal by cells
of the Mph lineage likely contributes to resolving inflammation
following influenza infection [63], likely through suppression of
pro-inflammatory cytokine production, induction of anti-inflam-
matory mediators, and promotion of tissue repair [22,26,64]. We
here report that influenza infection enhanced the uptake of
apoptotic epithelial cells and neutrophils (,4-fold) by poorly
phagocytic Mph1. The phagocytic capacity of Mph2, however,
was not affected following influenza infection, possibly because the
phagocytic capacity of Mph2 was already maximal. The observed
increase in phagocytosis was not mediated by a soluble product, as
shown by supernatant transfer experiments, so the functional
alteration likely represents a direct consequence of virus infection
rather than a secondary effect via released proteins.
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+ve and HA
2ve
Mph following infection (Figure 7D), but increasing virus dose
augmented cell uptake by HA
+ve Mph1 (Figure 7D). Influenza A
NS1 binds to and activates host cell phosphoinositide 3-Kinase
(PI3K) [62,65]. Since phagocytic uptake of apoptotic cells by Mph
critically depends on PI3K activation [66], it would be interesting
to see whether influenza A/Udorn mutant viruses that cannot
activate PI3K [62,65] fail to increase phagocytosis of apoptotic
cells by infected Mph. Unlike enhanced phagocytosis by
glucocorticoid–treated human Mph [67], influenza-induced
phagocytosis increase was independent of IL-10 or Mertk/Protein
S pathway. We speculate that expression of viral neuraminidase
(NA) contributes to increasing the phagocytic capacity of infected
Mph. Indeed, NA treatment of human Mph or apoptotic
neutrophils increases uptake of the latter [68,69], while surface
desialylation of Mph with viral NA affects uptake of virus-infected
target cells by uninfected murine Mph [70].
Augmenting phagocytosis by recruited inflammatory monocytes
and Mph1-like cells during influenza infection may have profound
consequences. Failure to suppress influenza-induced cytokines via
appropriate apoptotic cell uptake may result in excessive
inflammation and lung tissue damage, a suggestion supported by
the finding that inhibiting phagocytosis augments lung inflamma-
tion and fatality in influenza-infected mice [71]. Understanding
the impact of virus-infected apoptotic cells and phagocytes on
phagocyte responses in an influenza-infected lung may provide a
new angle for the development of therapeutics. Control of
apoptotic cell clearance in the inflamed lung may allow redirection
of disease outcome and restoration of homeostasis in the
respiratory tract as influenza infection progresses.
Materials and Methods
Ethics statement
The study was conducted according to the principles expressed
in the Declaration of Helsinki, and approved by the Lothian
Regional Ethics Committee, UK. Informed written consent was
obtained from all volunteers before donating blood.
Cell preparation
Human peripheral blood was taken from the antecubital vein of
healthy volunteers and collected into tubes containing sodium
citrate (1% final concentration) to prevent coagulation. Leukocyte
populations were then isolated by sedimentation with dextran
(500,000 M.wt) followed by discontinuous Percoll
TM gradient
centrifugation, as reported previously [72]. Macrophage subsets
were generated from the mononuclear cell fraction (MNC) as
described [26]. In short, monocytes were enriched by anti-CD14
microbeads magnetic cell sorting (Miltenyi Biotec), with a typical
purity of 95–98% as assessed by flow cytometry. CD14
+ve
monocytes were cultured for 6 days in tissue culture plates
(Costar) in Iscove’s Modified Dulbecco’s Medium (IMDM; PAA
Laboratories) containing penicillin/streptomycin (PPA Laborato-
ries, 50 U/ml) and 10% heat-inactivated FCS (Biosera), in the
presence of 50 U/ml GM-CSF (Peprotech) to generate Mph1, or
25 ng/ml M-CSF (R&D Systems) to generate Mph2. Following
stimulation with LPS (E.coli, serotype O127:B8, Sigma-Aldrich)
(10 ng/ml for 24 h) Mph1 cells secreted IL-12 but not IL-10,
while Mph2 secreted IL-10 but little IL-12, confirming macro-
phage polarization [26].
MNC were enriched for monocytes by depleting CD3
+ve cells
using anti-CD3 microbeads magnetic cell sorting (Miltenyi Biotec),
resulting in ,3-fold increase in the percentage of monocytes
present (from 15.9%61.9 (n=7) to 49.6%66 (n=5)). MNC were
maintained in IMDM containing 10% autologous serum and
penicillin/streptomycin (PPA Laboratories, 50 U/ml) in Teflon
pots (Pierce) (2610
6 cells/ml).
Airway epithelial A549 cells and Madin-Darby canine kidney
(MDCK) cells were obtained from the European Animal Cell
Culture Collection and maintained in Dulbecco’s modified Eagle
medium (DMEM) (Gibco DMEM/F-12+Glutamax, Invitrogen),
supplemented with penicillin/streptomycin (PPA Laboratories,
50 U/ml) and 10% heat-inactivated FCS (Biosera) [62].
Virus preparation and infection
Influenza A/Udorn/72 virus (Udorn; H3N2 subtype) was
prepared by Drs Jackson and Killip, St Andrews University, as
published previously [62]. In short, virus was propagated through two
passages in MDCK cells overlaid with serum-free DMEM containing
2.5 mg/mL N- a c e t y lt r y p s i n( N A T ,S i g m a )a t3 7 uC, followed by
plaque assay titration on MDCK cells. Viral titres of Udorn stock
solution and culture supernatants were determined with plaque
assays. MDCK cells were grown to near-confluency in 6 well-plates
and infected with 5-fold dilution series of virus in serum-free DMEM
at 37uC. After 1 h, the inoculum was removed and cells overlayed
with DMEM containing 1% agarose and 2 mg/ml NAT. After 48–
72 h cells were fixed for 1 h with 10% buffered formalin (Sigma) and
washed with PBS. After agar plug removal, plaques were counted by
eye and expressed as Plaque Forming Units (PFU)/ml.
Influenza infection of human MNC and monocytes was
performed by infecting 2610
6 cells with Udorn or UV-treated virus
(0.5 J/cm
2 for 6 min in a Uvitec cross linker) at indicated MOIs in
serum-free IMDM for 1 h at 37uC in Teflon pots, after which the
cells were collected by centrifugation (200 g, 3 min). Subsequently,
cells were cultured in 1 ml serum-containing medium in Teflon
pots. Influenza infection of human monocyte-derived macrophages,
A549 cells, MDCK cells and monocytes in experiments to assess a
possible effect of cell adherence on infectivity, was performed by
incubating 4610
5 cells with Udorn, or UV treated virus (0.5 J/cm
2
for 6 min) at indicated MOIs in serum-free medium for 1 h at 37uC
in 24 well tissue culture plates (Costar), after which the inoculum
was aspirated and cells cultured in 0.5 ml serum-containing
medium. At various times p.i. cell supernatants were stored at
220uC for future analyses, and cells were harvested for flow
cytometry (see below). We routinely performed CD14-labelling of
the cellsafter isolationand after infectionto confirm the populations
we analysed were indeed monocytes (CD14-high expressing cells
typically amounted to 89–93%).
To assess the role of caspase activity, cells were incubated with
the pan-caspase inhibitor Z-VAD(OMe)-FMK (Bachem) (100 mM)
for 30 min prior to infection with Udorn. zVAD was also present
in the culture medium (100 mM) during incubation of the cells
with virus and was added again after removal of the inoculum for
the duration of cell culture (100 mM).
Flow cytometric analysis
Cells were harvested from Teflon pots (MNC) or detached from
plates using trypsin/EDTA (PAA Laboratories) for 20 min at
37uC (macrophages, A549 cells and MDCK cells) or ice-cold
EDTA (Gibco; 5 mM) for 20 min on ice (monocytes). All
subsequent steps were performed on ice. Cells were incubated
for 10 min in PBS containing 50% autologous serum to reduce
non-specific antibody binding to FccR, and virus was inactivated
by UV cross-linking. Cells were incubated with FITC- or PE-
labelled antibodies or appropriate isotype controls (Becton-
Dickinson, UK), diluted in flow buffer (PBS/2% FCS) for 30 min.
To assess surface expression of influenza HA associated with
infectivity, cells were incubated with a mouse anti-HA antibody
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buffer, and then incubated with a polyclonal goat-anti mouse
immunoglobulins (Igs) secondary antibody (APC-conjugated,
multiple adsorption igs (Pharmingen, 0.4 mg/ml) or PE-conjugated
F(ab9)2 igs (DAKO, 1/350)). To assess apoptosis (AxV
+/PI
2) and
necrosis (AxV
+/PI
+) cells were stained with annexin V-APC
(Invitrogen) in binding buffer (HBSS containing 2 mM CaCl2) for
15 min on ice, followed by addition of propidium iodide (Sigma,
3 mg/ml), added 1 min prior to acquisition.
Data were acquired using a BD FACSCalibur flow cytometer
(Becton-Dickinson) using CELLQUEST software and subsequent-
ly analysed using FlowJo software (Tree Star).
Confocal microscopy
Slides were prepared from mock- and Udorn-infected MNC
cultured in Teflon pots (1610
5 cells/slide) using a Cytocentrifuge
(Shandon) at 200 g for 3 min. Cells were fixed with 3.6%
formaldehyde in PBS (15 min, RT), treated with 50 mM
ammonium chloride in PBS (10 min, RT) to block free
formaldehyde groups, permeabilised with 0.5% Triton X-100 in
PBS (5 min, RT) and blocked with 3% BSA in PBS (30 min, RT).
Cells were stained for 1 h at RT with 50 ml anti-AH (H3N2) (see
flow cytometry) (1/1000 in 0.3% BSA/PBS), followed by goat
anti-mouse AF488 (Invitrogen, 1/1000 in 0.3% BSA/PBS) plus
Hoechst 33342 (Invitrogen, 1 mg/ml in 0.3% BSA/PBS). After
washing, cells were mounted in Prolong Gold (Invitrogen), dried
O/N and analysed using a Leica SP5C Spectral confocal laser
scanning microscope (Leica Microsystems).
Phagocytosis assay
Human neutrophils were labelled for 30 min with CellTrack-
er
TM Green CMFDA (500 ng/ml; Invitrogen) as described [72]
and then cultured at 10610
6/ml in IMDM containing 10% heat-
inactivated FCS and penicillin/streptomycin (50 U/ml) for 20 h
at 37uC/5%CO2, resulting in spontaneous apoptosis [26].
Mph1 and Mph2 were mock-infected or Udorn-infected for 16 h
(MOI=1) and co-cultured with labelled apoptotic neutrophils in a
ratio of 1:5 in IMDM/10% FCS plus penicillin/streptomycin (50 U/
ml). For assessment of phagocytosis of latex microspheres, macro-
phages were incubated with 1 mm fluorescein-labelled Fluoresbrite
particles (Polysciences) (10/20/40 beads per cell). After 1 h at 37uC
non-internalised neutrophils or beads were removed by washing.
Macrophages were detached with trypsin/EDTA (20 min at 37uC)
and virus was then inactivated by UV cross-linking. The percentage
of Mph1 and Mph2 capable of phagocytosis was determined by flow
cytometry using a FACSCalibur, as described previously [26,72]. To
test the effect of cell supernatant of infected macrophages, culture
supernatants of mock- and Udorn-infected Mph1 and Mph2 were
harvested 12 h or 14 h p.i., UV-treated, and added to (autologous)
untreated Mph1 or Mph2, respectively, and left for 2 h or 4 h until
the phagocytosis assay.
To assess a potential role for Mertk, Protein S or IL-10 in
phagocytosis of apoptotic cells by influenza-infected macrophages,
mock- or Udorn-infected Mph1 and Mph2 were incubated with
an anti-Mer blocking antibody (R&D MAB8912; 5 mg/ml),
Protein S (Enzyme Research HPS3652L; 4 mg/ml) or recombi-
nant human IL-10 (Peprotech; 20 ng/ml) for 30 minutes before
addition of the apoptotic neutrophils. The reagents were also
present during the 1 h macrophage-neutrophil co-culture.
Cytokine detection
Cells were mock-infected or infected with Udorn at indicated
MOIs and times, or stimulated with 20 ng/ml LPS (E.coli,
serotype O127:B8, purchased from Sigma-Aldrich) for 20 h, and
secreted chemokines and cytokines quantified in UV-irradiated
supernatants using ELISAs (IP-10, IL-6, IL-8, IL-10, IL-12p40
and TNFa (optEIA, Beckton-Dickinson) and IL-33 (Legend Max,
Biolegend)).
Western blotting
Macrophages were infected as described above, in 6 well tissue
culture plates (2.5610
5 cells/well), and proteins extracted by lysing
cells 5 min with 150 ml/well M-PER Protein Extraction Reagent
(Pierce) containing protease inhibitor cocktail (Sigma, used at 1/
100). To assess the role of protein synthesis, cells were incubated
with cycloheximide (50 mg/ml; Sigma) for 30 min prior to
infection with Udorn. Cycloheximide was also present in the
culture medium following incubation of the cells with virus for the
duration of cell culture (50 mg/ml). To rule out interference of the
pan-caspase inhibitor zVAD with virus attachment, cells were
treated with zVAD prior, during and after virus–inoculation, as
described above. Lysates (15 ml) were mixed with sample buffer,
heat denatured and resolved on 12% Tris-HCl polyacrylamide
gels under reducing conditions, followed by transfer onto PVDF
membranes (Hybond-P, Amersham) (50V, 1 h). After blocking
with 5% Marvel in TBS/0.1% Tween buffer, membranes were
incubated with an affinity-purified sheep anti-influenza A NS1
antibody. Following incubation with HPR-conjugated polyclonal
rabbit-anti goat Igs secondary antibody (Dako; 1/2000), signal was
detected with chemiluminescence (ECL Plus Western Blotting
Detection Kit, Amersham) and exposure to Hyper ECL film
(Amersham). For subsequent detection of other Influenza A virus
proteins (HA, NP and M1) and mammalian b-actin, blots were
washed, stripped for 15 min with Pierce Restore WB Stripping
buffer (ThermoFisher), blocked for 1 h, and incubated with an
anti-Influenza A HA/NP/M1 antibody (sheep anti-X31 (H3N2))
or anti-b-Actin (Sigma, clone AC-15, 1/10,000), followed by
HPR-conjugated polyclonal rabbit-anti goat Igs secondary anti-
body (Dako; 1/2000) or HPR-conjugated polyclonal goat-anti
mouse Igs secondary antibody (Dako; 1/2000), respectively. A
lysate of Influenza A/Udorn infected A549 cells (16 h, MOI=5)
was used as a positive control.
Data Analysis
Data are presented as means 6 SD, with n=number of
independent experiments, or as means 6 SD of a representative
experiment performed in triplicate. Statistical significance was
evaluated using a Student’s t test.
Supporting Information
Figure S1 Influenza infection of human monocyte-
derived macrophages results in production of viral
proteins. Influenza infection with infectious, but not UV-
inactivated Udorn virus induces production of influenza A
proteins NS1 (26 kDa) (A) and HA0 (approximately 75 kDa), NP
(55 kDa) and M1 (26 kDa) (B) in human Mph1 cells, as assessed
by Western blotting of cell lysates of mock-infected, UV-
inactivated (MOI=5, 8 h p.i.) and infectious virus-infected cells
(MOI=2 and MOI=5, 8 h p.i.). None of these proteins were
detected in Udorn-infected cells (MOI=5) treated with protein
synthesis inhibitor cycloheximide, while b-Actin was readily
detected in all samples (C). A lysate of A549 cells infected for
16 h with Udorn virus (MOI=5) was run as a positive control.
Due to the presence of N-acetyl trypsin during infection of these
cells, HA was cleaved into HA1 (approximately 55 kDa) and HA2
(approximately 25 kDa), showing as additional 55 kD and 26 kD
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